Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho family GTPase 2 (RND2) is a small (~21 kDa) signaling G protein and a Rho family small GTPase encoded by the RND2 gene in humans. Members of the Rho GTPase family are key regulators of actin cytoskeleton organization in response to extracellular growth factors, and RND2 is specifically involved in the regulation of neuronal morphology, endosomal trafficking, and smooth muscle contractility. RND2 is unique within its family as it promotes RhoA signaling, in contrast to other Rnd proteins that antagonize RhoA signaling, impacting cytoskeletal dynamics and neurite outgrowth in neuronal cells. It is expressed in neuronal tissues (e.g., cortical and hippocampal regions), in neuron-like PC12 cells, and in uterine myometrial tissues. Mutations or dysfunction in RND2 are linked to rare developmental syndromes but no drugs currently target this protein. RND2’s main functions are intracellular signaling and cytoskeletal modulation rather than acting as an extracellular receptor or conventional drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho family GTPase 2 (RND2).